PBYI
PUMA BIOTECHNOLOGY, INC.
Company overview
- Market capitalization
- $506.91M
- Employees
- 179
- Latest publication
- 2026-09-29
About PUMA BIOTECHNOLOGY, INC.
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. It offers NERLYNX, an oral version of neratinib that is used to treat adult patients with early stage HER2-overexpressed/amplified breast cancer; and advanced or metastatic HER2-positive breast cancer when combined with capecitabine. The company also develops alisertib, a small molecule inhibitor of aurora kinase A for the treatment of hormone receptor positive breast cancer, triple negative breast cancer, small cell lung cancer, and head and neck cancer. It sells its products through specialty pharmacy and distributor networks. The company has license agreements with Pfizer Inc. for the development, manufacture, and commercialization of neratinib (oral), neratinib (intravenous), PB357, and related compounds, as well as sub-license agreements with Specialised Therapeutics Asia Pte Ltd., Medison Pharma Ltd., Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. Puma Biotechnology, Inc. was founded in 2010 and is headquartered in Los Angeles, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q4 20232023-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 56,502,000USD | 75,453,000USD | 54,475,000USD | 52,436,000USD | 46,007,000USD | 59,077,000USD | 80,542,000USD | 72,178,000USD |
| Cost Of Revenue | 12,475,000USD | 23,127,000USD | 12,173,000USD | 12,301,000USD | 10,556,000USD | 13,921,000USD | 29,097,000USD | 24,323,000USD |
| Gross Profit | 44,027,000USD | 52,326,000USD | 42,302,000USD | 40,135,000USD | 35,451,000USD | 45,156,000USD | 51,445,000USD | 47,855,000USD |
| Selling General Administrative | 17,547,000USD | 18,379,000USD | 17,030,000USD | 18,409,000USD | 17,391,000USD | 17,020,000USD | 16,867,000USD | 19,817,000USD |
| Total Operating Expenses | 36,442,000USD | 35,220,000USD | 32,729,000USD | 33,499,000USD | 31,467,000USD | 31,791,000USD | 29,366,000USD | 33,057,000USD |
| Operating Income | 7,585,000USD | 17,106,000USD | 9,573,000USD | 6,636,000USD | 3,984,000USD | 13,365,000USD | 22,079,000USD | 14,798,000USD |
| Total Other Income Expense Net | 660,000USD | 1,000USD | -330,000USD | -471,000USD | -717,000USD | -1,127,000USD | -1,471,000USD | -1,994,000USD |
| Interest Income | 831,000USD | 977,000USD | 1,044,000USD | 956,000USD | 1,101,000USD | 1,226,000USD | 1,282,000USD | 719,000USD |
| Interest Expense | 180,000USD | 1,119,000USD | 1,489,000USD | 1,837,000USD | 2,177,000USD | 2,621,000USD | 3,100,000USD | 3,354,000USD |
| Income Before Tax | 8,245,000USD | 17,107,000USD | 9,243,000USD | 6,165,000USD | 3,267,000USD | 12,238,000USD | 20,608,000USD | 12,804,000USD |
| Income Tax Expense | 56,000USD | 3,669,000USD | 399,000USD | 310,000USD | 293,000USD | -7,067,000USD | 291,000USD | 536,000USD |
| Net Income | 8,189,000USD | 13,438,000USD | 8,844,000USD | 5,855,000USD | 2,974,000USD | 19,305,000USD | 20,317,000USD | 12,268,000USD |
| Research Development | — | 16,841,000USD | 15,912,000USD | 15,452,000USD | 13,863,000USD | 15,169,000USD | 12,547,000USD | 12,873,000USD |
| Net Interest Income | — | -142,000USD | -445,000USD | -881,000USD | -1,076,000USD | -1,395,000USD | -1,818,000USD | -2,635,000USD |
| Tax Provision | — | 3,669,000USD | 399,000USD | 310,000USD | 293,000USD | -7,067,000USD | 291,000USD | 536,000USD |
| Net Income From Continuing Ops | — | 13,438,000USD | 8,844,000USD | 5,855,000USD | 2,974,000USD | 19,305,000USD | 20,317,000USD | 12,268,000USD |
| Ebit | — | 18,226,000USD | 10,732,000USD | 8,002,000USD | 5,444,000USD | 14,859,000USD | 23,708,000USD | 15,423,000USD |
| Ebitda | — | 20,883,000USD | 13,454,000USD | 10,765,000USD | 8,240,000USD | 17,700,000USD | 26,586,000USD | 18,312,000USD |
| Depreciation And Amortization | — | 2,657,000USD | 2,722,000USD | 2,763,000USD | 2,796,000USD | 2,841,000USD | 2,878,000USD | 2,889,000USD |
| Reconciled Depreciation | — | 2,657,000USD | 2,722,000USD | 2,763,000USD | 2,796,000USD | 2,841,000USD | 2,878,000USD | 2,889,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 367,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20162016-12-31 · USD | FY 20152015-12-31 · USD | FY 20142014-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 228,371,000USD | 230,468,000USD | 235,637,000USD | 228,031,000USD | 253,155,000USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 58,157,000USD | 64,404,000USD | 62,682,000USD | 55,093,000USD | 63,701,000USD | 1,149,000USD | 776,000USD | 0USD |
| Gross Profit | 170,214,000USD | 166,064,000USD | 172,955,000USD | 172,938,000USD | 189,454,000USD | -1,149,000USD | -776,000USD | 0USD |
| Research Development | 62,068,000USD | 54,935,000USD | 50,382,000USD | 52,240,000USD | 71,870,000USD | 222,800,000USD | 208,500,000USD | 122,900,000USD |
| Selling General Administrative | 71,209,000USD | 80,682,000USD | 88,427,000USD | 89,978,000USD | 116,294,000USD | 53,800,000USD | 31,800,000USD | 19,400,000USD |
| Total Operating Expenses | 132,915,000USD | 135,098,000USD | 140,315,000USD | 149,218,000USD | 188,164,000USD | 276,600,000USD | 240,300,000USD | 142,300,000USD |
| Operating Income | 37,299,000USD | 30,966,000USD | 32,640,000USD | 23,720,000USD | 1,290,000USD | -276,600,000USD | -240,300,000USD | -142,300,000USD |
| Interest Income | 4,078,000USD | 4,724,000USD | 2,405,000USD | 813,000USD | 160,000USD | 958,000USD | — | — |
| Interest Expense | 6,622,000USD | 12,452,000USD | 13,330,000USD | 11,592,000USD | 12,807,000USD | 958,000USD | 971,000USD | 324,000USD |
| Net Interest Income | -2,544,000USD | -7,728,000USD | -10,850,000USD | -10,779,000USD | -12,647,000USD | 958,000USD | — | — |
| Income Before Tax | 35,782,000USD | 24,100,000USD | 22,674,000USD | 457,000USD | -28,802,000USD | -276,000,000USD | -239,300,000USD | -142,000,000USD |
| Income Tax Expense | 4,671,000USD | -6,178,000USD | 1,083,000USD | 455,000USD | 324,000USD | -2,149,000USD | -1,751,000USD | -941,000USD |
| Tax Provision | 4,671,000USD | -6,178,000USD | 841,000USD | 455,000USD | 324,000USD | — | — | — |
| Net Income | 31,111,000USD | 30,278,000USD | 21,591,000USD | 2,000USD | -29,126,000USD | -276,000,000USD | -239,300,000USD | -142,000,000USD |
| Net Income From Continuing Ops | 31,111,000USD | 30,278,000USD | 3,717,000USD | 2,000USD | -29,126,000USD | -276,011,000USD | -239,284,000USD | -141,965,000USD |
| Ebit | 42,404,000USD | 36,552,000USD | 36,004,000USD | 12,049,000USD | -15,995,000USD | -276,600,000USD | -240,300,000USD | -142,300,000USD |
| Ebitda | 53,342,000USD | 48,076,000USD | 47,523,000USD | 21,889,000USD | -4,690,000USD | -275,451,000USD | -239,524,000USD | -141,673,000USD |
| Depreciation And Amortization | 10,938,000USD | 11,524,000USD | 11,519,000USD | 9,840,000USD | 11,305,000USD | 1,149,000USD | 776,000USD | 627,000USD |
| Reconciled Depreciation | 10,938,000USD | 11,524,000USD | 10,163,000USD | 8,920,000USD | 10,598,000USD | — | — | — |
| Total Other Income Expense Net | -1,517,000USD | -6,866,000USD | -9,966,000USD | -23,263,000USD | -30,092,000USD | -400,000USD | 25,000USD | -14,000USD |
| Selling And Marketing Expenses | — | -519,000USD | 881,000USD | 22,000USD | 6,000USD | — | — | — |
| Unclassified Operating Expenses | — | — | — | 6,978,000USD | — | — | — | — |
| Non Operating Income Net Other | — | — | — | -11,671,000USD | -17,285,000USD | 585,000USD | 996,000USD | 310,000USD |
| Net Income Applicable To Common Shares | — | — | — | 2,000USD | -29,126,000USD | -276,011,000USD | -239,284,000USD | -141,965,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 192,736,000USD | 192,699,000USD | 216,302,000USD | 202,862,000USD | 194,916,000USD | 196,181,000USD | 213,333,000USD | 220,721,000USD |
| Cash And Equivalents | 36,537,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 93,903,000USD | 101,545,000USD | 97,528,000USD | 94,388,000USD | 96,024,000USD | 93,167,000USD | 100,965,000USD | 96,725,000USD |
| Short Term Investments | 57,366,000USD | 65,352,000USD | 67,893,000USD | 40,863,000USD | 41,362,000USD | 30,137,000USD | 31,746,000USD | 29,462,000USD |
| Total Current Assets | 145,072,000USD | 142,259,000USD | 162,686,000USD | 143,580,000USD | 136,578,000USD | 132,510,000USD | 147,658,000USD | 156,817,000USD |
| Other Current Assets | 199,000USD | 5,692,000USD | 5,989,000USD | 6,151,000USD | 6,053,000USD | 5,420,000USD | 5,958,000USD | 2,776,000USD |
| Total Liabilities | 54,192,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 49,825,000USD | 59,737,000USD | 81,253,000USD | 82,728,000USD | 79,099,000USD | 86,663,000USD | 96,111,000USD | 110,397,000USD |
| Other Current Liabilities | 0USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 138,544,000USD | 128,416,000USD | 130,340,000USD | 115,268,000USD | 104,718,000USD | 97,108,000USD | 92,125,000USD | 71,088,000USD |
| Total Equity Including Noncontrolling Interest | 138,544,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 0USD | 11,283,000USD | 22,523,000USD | 33,716,000USD | 33,997,000USD | 45,329,000USD | 45,329,000USD | 45,329,000USD |
| Net Receivables | 34,060,000USD | 26,329,000USD | 53,654,000USD | 33,565,000USD | 25,910,000USD | 25,172,000USD | 32,011,000USD | 54,643,000USD |
| Inventory | 13,324,000USD | 8,693,000USD | 5,515,000USD | 9,476,000USD | 8,591,000USD | 8,751,000USD | 8,724,000USD | 2,673,000USD |
| Property Plant Equipment Net | 4,523,000USD | 4,698,000USD | 5,560,000USD | 6,452,000USD | 3,216,000USD | 4,190,000USD | 5,094,000USD | 6,018,000USD |
| Accounts Payable | 3,105,000USD | 8,166,000USD | 5,056,000USD | 6,386,000USD | 5,424,000USD | 6,026,000USD | 5,509,000USD | 7,509,000USD |
| Short Term Debt | 450,000USD | 11,408,000USD | 23,837,000USD | 36,186,000USD | 38,361,000USD | 51,067,000USD | 50,869,000USD | 50,676,000USD |
| Common Stock | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD |
| Retained Earnings | -1,279,339,000USD | -1,287,528,000USD | -1,283,775,000USD | -1,297,213,000USD | -1,306,057,000USD | -1,311,912,000USD | -1,314,886,000USD | -1,334,191,000USD |
| Accumulated Other Comprehensive Income | -45,000USD | -31,000USD | 36,000USD | 18,999USD | -14,000USD | -11,000USD | 6,000USD | 26,000USD |
| Intangible Assets | — | 38,957,000USD | 41,392,000USD | 43,827,000USD | 46,262,000USD | 48,697,000USD | 51,131,000USD | 53,566,000USD |
| Total Liab | — | 64,283,000USD | 85,962,000USD | 87,594,000USD | 90,198,000USD | 99,073,000USD | 121,208,000USD | 149,633,000USD |
| Other Current Liab | — | 40,163,000USD | 52,360,000USD | 40,156,000USD | 35,314,000USD | 29,570,000USD | 39,733,000USD | 52,212,000USD |
| Capital Stock | — | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD |
| Cash | — | 36,193,000USD | 29,635,000USD | 53,525,000USD | 54,662,000USD | 63,030,000USD | 69,219,000USD | 67,263,000USD |
| Net Debt | — | -20,239,000USD | -1,089,000USD | -12,473,000USD | -5,432,000USD | -1,316,000USD | 4,863,000USD | 19,107,000USD |
| Short Long Term Debt Total | — | 15,954,000USD | 28,546,000USD | 41,052,000USD | 49,230,000USD | 61,714,000USD | 74,082,000USD | 86,370,000USD |
| Property Plant Equipment Gross | — | 7,586,000USD | 10,158,000USD | 13,041,000USD | 11,292,000USD | 12,160,000USD | 12,962,000USD | 13,993,000USD |
| Common Stock Shares Outstanding | — | 50,845,130shares | 51,521,371shares | 50,929,893shares | 50,144,704shares | 49,906,341shares | 49,408,877shares | 49,173,361shares |
| Non Current Assets Total | — | 50,440,000USD | 53,616,000USD | 59,282,000USD | 58,338,000USD | 63,671,000USD | 65,675,000USD | 63,904,000USD |
| Non Current Liabilities Total | — | 4,546,000USD | 4,709,000USD | 4,866,000USD | 11,099,000USD | 12,410,000USD | 25,097,000USD | 39,236,000USD |
| Non Currrent Assets Other | — | 2,955,000USD | 2,834,000USD | 9,003,000USD | 1,785,000USD | 3,709,000USD | 2,375,000USD | 2,229,000USD |
| Net Working Capital | — | 82,522,000USD | 81,433,000USD | 60,852,000USD | 57,479,000USD | 45,847,000USD | 51,547,000USD | 46,420,000USD |
| Unclassified Non Current Assets | — | 3,830,000USD | 3,830,000USD | — | 7,075,000USD | 7,075,000USD | 7,075,000USD | 2,091,000USD |
| Unclassified Current Liabilities | — | -11,283,000USD | -22,523,000USD | -33,716,000USD | -33,997,000USD | -45,329,000USD | -45,329,000USD | -45,329,000USD |
| Unclassified Non Current Liabilities | — | 4,546,000USD | 4,709,000USD | 4,866,000USD | — | — | 1,615,000USD | 3,069,000USD |
| Unclassified Equity | — | 1,415,965,000USD | 1,414,069,000USD | 1,412,452,001USD | 1,410,779,000USD | 1,409,021,000USD | 1,406,995,000USD | 1,405,243,000USD |
| Long Term Debt | — | — | — | — | 10,869,000USD | 10,647,000USD | 21,719,000USD | 32,746,000USD |
| Non Current Liabilities Other | — | — | — | — | 230,000USD | 1,763,000USD | 1,763,000USD | 3,421,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 216,302,000USD | 213,333,000USD | 230,528,000USD | 222,059,000USD | 226,585,000USD | 244,220,000USD | 234,905,000USD | 259,122,000USD |
| Intangible Assets | 41,392,000USD | 51,131,000USD | 60,871,000USD | 70,610,000USD | 66,125,000USD | 74,140,000USD | 40,461,000USD | 44,408,000USD |
| Other Current Assets | 5,989,000USD | 5,958,000USD | 4,677,000USD | 6,411,000USD | 18,281,000USD | 23,753,000USD | 22,586,000USD | 13,009,000USD |
| Total Liab | 85,962,000USD | 121,208,000USD | 177,086,000USD | 200,451,000USD | 229,031,000USD | 250,171,000USD | 217,442,000USD | 224,816,000USD |
| Total Stockholder Equity | 130,340,000USD | 92,125,000USD | 53,442,000USD | 21,608,000USD | -2,446,000USD | -5,951,000USD | 17,463,000USD | 34,306,000USD |
| Other Current Liab | 52,360,000USD | 39,733,000USD | 53,696,000USD | 66,904,000USD | 94,838,000USD | 84,799,000USD | 69,030,000USD | 46,431,000USD |
| Common Stock | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD |
| Capital Stock | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD |
| Retained Earnings | -1,283,775,000USD | -1,314,886,000USD | -1,345,164,000USD | -1,366,755,000USD | -1,366,757,000USD | -1,337,631,000USD | -1,277,636,000USD | -1,202,041,000USD |
| Cash | 29,635,000USD | 69,219,000USD | 84,585,000USD | 76,201,000USD | 63,131,000USD | 85,293,000USD | 60,037,000USD | 108,400,000USD |
| Cash And Short Term Investments | 97,528,000USD | 100,965,000USD | 95,939,000USD | 81,074,000USD | 82,106,000USD | 93,389,000USD | 111,644,000USD | 108,400,000USD |
| Total Current Assets | 162,686,000USD | 147,658,000USD | 156,185,000USD | 134,281,000USD | 140,022,000USD | 146,139,000USD | 166,296,000USD | 203,003,000USD |
| Total Current Liabilities | 81,253,000USD | 96,111,000USD | 99,382,000USD | 77,484,000USD | 109,586,000USD | 114,255,000USD | 90,837,000USD | 67,115,000USD |
| Net Debt | -1,089,000USD | 4,863,000USD | 26,905,000USD | 38,080,000USD | 53,510,000USD | 35,661,000USD | 60,192,000USD | 43,486,000USD |
| Short Term Debt | 23,837,000USD | 50,869,000USD | 38,797,000USD | 4,140,000USD | 3,574,000USD | 17,380,000USD | 2,624,000USD | — |
| Short Long Term Debt | 22,523,000USD | 45,329,000USD | 33,997,000USD | — | — | 14,286,000USD | — | — |
| Short Long Term Debt Total | 28,546,000USD | 74,082,000USD | 111,490,000USD | 114,281,000USD | 116,641,000USD | 120,954,000USD | 120,229,000USD | 151,886,000USD |
| Short Term Investments | 67,893,000USD | 31,746,000USD | 11,354,000USD | 4,873,000USD | 18,975,000USD | 8,096,000USD | 51,607,000USD | 57,000,000USD |
| Net Receivables | 53,654,000USD | 32,011,000USD | 48,489,000USD | 42,270,000USD | 32,526,000USD | 25,543,000USD | 28,896,000USD | 21,948,000USD |
| Inventory | 5,515,000USD | 8,724,000USD | 7,080,000USD | 4,526,000USD | 7,109,000USD | 3,454,000USD | 3,170,000USD | 2,625,000USD |
| Accounts Payable | 5,056,000USD | 5,509,000USD | 6,889,000USD | 6,440,000USD | 11,174,000USD | 12,076,000USD | 19,183,000USD | 20,684,000USD |
| Property Plant Equipment Net | 5,560,000USD | 5,094,000USD | 8,647,000USD | 12,508,000USD | 15,773,000USD | 18,885,000USD | 21,826,000USD | 3,963,000USD |
| Property Plant Equipment Gross | 10,158,000USD | 12,962,000USD | 16,327,000USD | 1,146,000USD | 22,634,000USD | 18,885,000USD | 21,826,000USD | 3,963,000USD |
| Accumulated Other Comprehensive Income | 36,000USD | 6,000USD | -4,000USD | 0USD | -2,000USD | 0USD | 62,000USD | -12,000USD |
| Common Stock Shares Outstanding | 50,653,283shares | 49,100,433shares | 47,550,852shares | 44,929,998shares | 40,638,852shares | 39,576,107shares | 38,768,653shares | 37,942,411shares |
| Non Current Assets Total | 53,616,000USD | 65,675,000USD | 74,343,000USD | 87,778,000USD | 86,563,000USD | 98,081,000USD | 68,609,000USD | 56,119,000USD |
| Non Current Liabilities Total | 4,709,000USD | 25,097,000USD | 77,704,000USD | 122,967,000USD | 119,445,000USD | 135,916,000USD | 126,605,000USD | 157,701,000USD |
| Non Currrent Assets Other | 2,834,000USD | 2,375,000USD | 2,734,000USD | 4,660,000USD | 4,665,000USD | 5,056,000USD | 6,322,000USD | 6,011,000USD |
| Net Working Capital | 81,433,000USD | 51,547,000USD | 56,803,000USD | 56,797,000USD | 30,436,000USD | 31,884,000USD | 75,459,000USD | 135,888,000USD |
| Unclassified Non Current Assets | 3,830,000USD | 7,075,000USD | 2,090,999USD | -4,660,000USD | -4,665,000USD | -5,056,000USD | -6,322,000USD | -6,011,000USD |
| Unclassified Current Liabilities | -22,523,000USD | -45,329,000USD | -33,997,000USD | -5,902,000USD | -92,575,000USD | -96,604,000USD | — | — |
| Unclassified Non Current Liabilities | 4,709,000USD | 1,615,000USD | 7,155,000USD | 6,399,000USD | -7,121,000USD | -33,297,000USD | -9,868,000USD | -5,815,000USD |
| Unclassified Equity | 1,414,069,000USD | 1,406,995,000USD | 1,398,600,000USD | 1,388,353,000USD | 1,364,305,000USD | 1,331,672,000USD | 1,295,029,000USD | 1,236,351,000USD |
| Long Term Debt | — | 21,719,000USD | 65,659,000USD | 98,307,000USD | 97,092,000USD | 84,025,000USD | 94,962,000USD | 151,886,000USD |
| Non Current Liabilities Other | — | 1,763,000USD | 4,890,000USD | 5,435,000USD | 22,353,000USD | 51,891,000USD | 31,643,000USD | — |
| Other Assets | — | — | 1USD | 4,660,000USD | 4,665,000USD | 5,056,000USD | 6,322,000USD | 7,748,000USD |
| Other Liab | — | — | — | 12,826,000USD | 6,378,000USD | 32,342,000USD | 9,000,000USD | 5,815,000USD |
| Current Deferred Revenue | — | — | — | 5,902,000USD | 92,575,000USD | 82,318,000USD | — | — |
| Net Tangible Assets | — | — | — | 21,608,000USD | -68,571,000USD | -80,091,000USD | -22,998,000USD | -10,102,000USD |
| Deferred Long Term Liab | — | — | — | — | 743,000USD | 955,000USD | 868,000USD | 5,815,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -3,753,000USD | 13,438,000USD | 8,844,000USD | 5,855,000USD | 2,974,000USD | 19,305,000USD | 20,317,000USD | -4,529,000USD |
| Depreciation | 2,584,000USD | 2,657,000USD | 2,722,000USD | 2,763,000USD | 2,796,000USD | 2,841,000USD | 2,878,000USD | 2,908,000USD |
| Stock Based Compensation | 1,896,000USD | 1,617,000USD | 1,673,000USD | 1,628,000USD | 2,026,000USD | 1,752,000USD | 2,054,000USD | 2,062,000USD |
| Other Non Cash Items | 6,000USD | 3,245,000USD | -209,000USD | -362,000USD | 213,000USD | -398,000USD | -48,000USD | -183,000USD |
| Change To Account Receivables | 27,325,000USD | -20,089,000USD | -7,442,000USD | -376,000USD | 6,626,000USD | 23,030,000USD | -26,490,000USD | -3,338,000USD |
| Change To Inventory | -3,178,000USD | 3,961,000USD | -885,000USD | 160,000USD | -27,000USD | -6,051,000USD | 6,376,000USD | -1,949,000USD |
| Change In Working Capital | 14,683,000USD | -6,538,000USD | -3,341,000USD | 4,198,000USD | -4,397,000USD | -818,000USD | -14,163,000USD | 769,000USD |
| Total Cash From Operating Activities | 15,416,000USD | 14,419,000USD | 9,689,000USD | 14,082,000USD | 3,612,000USD | 15,607,000USD | 11,038,000USD | 1,027,000USD |
| Capital Expenditures | 0USD | -36,000USD | -26,000USD | -20,000USD | -61,000USD | -16,000USD | -20,000USD | -20,000USD |
| Free Cash Flow | 15,416,000USD | 14,455,000USD | 9,663,000USD | 14,062,000USD | 3,551,000USD | 15,591,000USD | 11,018,000USD | 1,007,000USD |
| Investments | 2,474,000USD | -27,013,000USD | 506,000USD | -11,248,000USD | 1,531,000USD | -2,320,000USD | 259,000USD | 703,000USD |
| Total Cashflows From Investing Activities | 2,474,000USD | -26,977,000USD | 506,000USD | -11,248,000USD | 1,531,000USD | -2,320,000USD | 259,000USD | 703,000USD |
| Net Borrowings | -11,110,000USD | -11,110,000USD | -11,110,000USD | -11,110,000USD | -11,110,000USD | -11,110,000USD | -11,110,000USD | — |
| Total Cash From Financing Activities | -11,300,000USD | -11,332,000USD | -11,332,000USD | -11,202,000USD | -11,332,000USD | -11,331,000USD | -11,183,000USD | -11,332,000USD |
| Change In Cash | 6,558,000USD | -23,890,000USD | -1,137,000USD | -8,368,000USD | -6,189,000USD | 1,956,000USD | 114,000USD | -9,602,000USD |
| Begin Period Cash Flow | 31,726,000USD | 55,616,000USD | 56,753,000USD | 65,121,000USD | 71,310,000USD | 69,354,000USD | 69,240,000USD | 76,751,000USD |
| End Period Cash Flow | 38,284,000USD | 31,726,000USD | 55,616,000USD | 56,753,000USD | 65,121,000USD | 71,310,000USD | 69,354,000USD | 67,149,000USD |
| Other Cashflows From Financing Activities | -190,000USD | -222,000USD | -222,000USD | -222,000USD | -222,000USD | -221,000USD | -223,000USD | -222,000USD |
| Other Cashflows From Investing Activities | — | -18,800,000USD | — | — | — | — | — | 723,000USD |
| Unclassified Investing Cash Flow | — | 18,872,000USD | — | — | — | — | — | — |
| Unclassified Operating Cash Flow | — | — | — | — | — | -7,075,000USD | — | — |
| Unclassified Financing Cash Flow | — | — | — | — | — | — | — | -11,110,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 31,111,000USD | 30,278,000USD | 21,591,000USD | 2,000USD | -29,126,000USD | -59,995,000USD | -75,595,000USD | -113,575,000USD |
| Depreciation | 10,938,000USD | 11,524,000USD | 11,519,000USD | 9,840,000USD | 11,305,000USD | 10,033,000USD | 8,077,000USD | 7,384,000USD |
| Stock Based Compensation | 6,944,000USD | 8,245,000USD | 10,247,000USD | 11,826,000USD | 32,633,000USD | 36,575,000USD | 57,327,000USD | 86,939,000USD |
| Other Non Cash Items | -358,000USD | -519,000USD | 1,506,000USD | 7,001,000USD | 7,147,000USD | 1,027,000USD | 9,284,000USD | 289,000USD |
| Change To Account Receivables | -21,281,000USD | 16,345,000USD | -8,368,000USD | -7,824,000USD | -5,983,000USD | 2,353,000USD | -8,123,000USD | -11,103,000USD |
| Change To Inventory | 3,209,000USD | -1,644,000USD | -2,554,000USD | 2,583,000USD | -3,655,000USD | -284,000USD | -545,000USD | -596,000USD |
| Change In Working Capital | -10,078,000USD | -3,535,000USD | -17,854,000USD | -44,496,000USD | -1,309,000USD | 13,160,000USD | 23,283,000USD | -5,142,000USD |
| Total Cash From Operating Activities | 41,802,000USD | 38,918,000USD | 27,009,000USD | -15,827,000USD | 20,650,000USD | 800,000USD | 22,376,000USD | -24,100,000USD |
| Capital Expenditures | -71,000USD | -56,000USD | -12,640,000USD | -7,000,000USD | -1,000USD | -20,046,000USD | -306,000USD | -609,000USD |
| Free Cash Flow | 41,731,000USD | 38,862,000USD | 14,369,000USD | -22,827,000USD | 20,650,000USD | -19,246,000USD | 22,070,000USD | -24,709,000USD |
| Investments | -36,117,000USD | -20,438,000USD | -22,828,000USD | 14,104,000USD | -10,881,000USD | 43,449,000USD | 5,469,000USD | -57,014,000USD |
| Total Cashflows From Investing Activities | -36,188,000USD | -20,438,000USD | -19,125,000USD | 7,104,000USD | -10,881,000USD | 23,300,000USD | 5,163,000USD | -57,600,000USD |
| Net Borrowings | -44,440,000USD | -33,330,000USD | 0USD | 0USD | -1,500,000USD | -1,500,000USD | -68,418,000USD | 100,799,000USD |
| Total Cash From Financing Activities | -45,198,000USD | -33,846,000USD | 2,431,000USD | 12,223,000USD | -31,931,000USD | 100,000USD | -67,067,000USD | 108,400,000USD |
| Change In Cash | -39,584,000USD | -15,366,000USD | 7,884,000USD | 3,500,000USD | -22,162,000USD | 24,244,000USD | -39,528,000USD | 26,723,000USD |
| Begin Period Cash Flow | 71,310,000USD | 86,676,000USD | 78,792,000USD | 75,292,000USD | 97,454,000USD | 73,210,000USD | 112,738,000USD | 86,015,000USD |
| End Period Cash Flow | 31,726,000USD | 71,310,000USD | 86,676,000USD | 78,792,000USD | 75,292,000USD | 97,454,000USD | 73,210,000USD | 112,738,000USD |
| Other Cashflows From Financing Activities | -888,000USD | -666,000USD | -19,125,000USD | -277,000USD | -30,431,000USD | 32,000USD | -12,067,000USD | -4,252,000USD |
| Unclassified Operating Cash Flow | 3,245,000USD | -7,075,000USD | — | — | — | — | — | — |
| Issuance Of Capital Stock | — | 0USD | 2,500,000USD | 12,500,000USD | 0USD | 0USD | — | 0USD |
| Other Cashflows From Investing Activities | — | — | -12,500,000USD | -4,000USD | -19,000USD | -20,103,000USD | 37,000USD | -170,000USD |
| Unclassified Investing Cash Flow | — | — | 28,843,000USD | — | — | 20,000,000USD | — | — |
| Unclassified Financing Cash Flow | — | — | 19,056,000USD | — | — | 1,500,000USD | 12,067,000USD | 4,201,000USD |
| Change To Liabilities | — | — | — | -37,799,000USD | -902,000USD | 12,144,000USD | 21,073,000USD | 8,775,000USD |
| Sale Purchase Of Stock | — | — | — | 12,223,000USD | — | 68,000USD | 1,351,000USD | 7,652,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 3,500,000USD | -22,162,000USD | 24,244,000USD | -39,528,000USD | 26,723,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Product | Product | 53,560,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Royalty | 2,942,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | Product | 41,959,000 | USD | 0001437749-26-015633 |
| Q1 2026Quarterly · 2026-03-31 | Product | Royalty | 2,855,000 | USD | 0001437749-26-015633 |
| Q4 2025Quarterly · 2025-12-31 | Product | Product | 59,880,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Royalty | 15,573,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Product | Product | 204,074,000 | USD | 0001437749-26-005891 |
| FY 2025Yearly · 2025-12-31 | Product | Royalty | 24,297,000 | USD | 0001437749-26-005891 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product | 51,902,000 | USD | 0001437749-25-033633 |
| Q3 2025Quarterly · 2025-09-30 | Product | Royalty | 2,573,000 | USD | 0001437749-25-033633 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product | 49,188,000 | USD | 0001437749-25-025470 |
| Q2 2025Quarterly · 2025-06-30 | Product | Royalty | 3,248,000 | USD | 0001437749-25-025470 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product | 43,104,000 | USD | 0001437749-26-015633 |
| Q1 2025Quarterly · 2025-03-31 | Product | Royalty | 2,903,000 | USD | 0001437749-26-015633 |
| Q4 2024Quarterly · 2024-12-31 | Product | Product | 54,376,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Royalty | 4,701,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Product | Product | 195,186,000 | USD | 0001437749-26-005891 |
| FY 2024Yearly · 2024-12-31 | Product | Royalty | 35,282,000 | USD | 0001437749-26-005891 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product | 56,136,000 | USD | 0001437749-25-033633 |
| Q3 2024Quarterly · 2024-09-30 | Product | Royalty | 24,406,000 | USD | 0001437749-25-033633 |
| FY 2023Yearly · 2023-12-31 | Product | License | 0 | USD | 0001437749-24-006121 |
| FY 2023Yearly · 2023-12-31 | Product | Product | 203,107,000 | USD | 0001437749-24-006121 |
| FY 2023Yearly · 2023-12-31 | Product | Royalty | 32,530,000 | USD | 0001437749-24-006121 |
| FY 2022Yearly · 2022-12-31 | Product | License | 0 | USD | 0001437749-24-006121 |
| FY 2022Yearly · 2022-12-31 | Product | Product | 200,023,000 | USD | 0001437749-24-006121 |
| FY 2022Yearly · 2022-12-31 | Product | Royalty | 28,008,000 | USD | 0001437749-24-006121 |
| FY 2021Yearly · 2021-12-31 | Product | License | 51,750,000 | USD | 0001437749-24-006121 |
| FY 2021Yearly · 2021-12-31 | Product | Product | 189,064,000 | USD | 0001437749-24-006121 |
| FY 2021Yearly · 2021-12-31 | Product | Royalty | 12,341,000 | USD | 0001437749-24-006121 |
| FY 2020Yearly · 2020-12-31 | Product | License | 22,700,000 | USD | 0001437749-23-005233 |
| FY 2020Yearly · 2020-12-31 | Product | Product | 196,728,000 | USD | 0001437749-23-005233 |
| FY 2020Yearly · 2020-12-31 | Product | Royalty | 5,682,000 | USD | 0001437749-23-005233 |
| FY 2019Yearly · 2019-12-31 | Product | License | 60,250,000 | USD | 0001437749-22-005164 |
| FY 2019Yearly · 2019-12-31 | Product | Product | 211,619,000 | USD | 0001437749-22-005164 |
| FY 2019Yearly · 2019-12-31 | Product | Royalty | 391,000 | USD | 0001437749-22-005164 |
| FY 2018Yearly · 2018-12-31 | Product | License | 50,500,000 | USD | 0001564590-21-009840 |
| FY 2018Yearly · 2018-12-31 | Product | Product | 200,491,000 | USD | 0001564590-21-009840 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.